// App-Quantinova.ai

Su1762 : Clinical and Molecular Characterization of Medically Refractory Acute, Severe Colitis: Preliminary Results From the International Inflammatory Bowel Disease Genetics Consortium (Iibdgc) Immunochip Study

Researchers

Presenter

  • James D. Doecke

Principal Investigators

  • Vito Annese

  • Rinse K. Weersma

  • Ian C. Lawrance

  • Stephan Brand

  • Steven R. Brant

  • Tariq Ahmad

  • Krupa Krishnaprasad

  • L. Philip Schumm

  • Mark S. Silverberg

  • Jonas Halfvarson

  • Dermot P. McGovern

  • Severine Vermeire

  • D. Turner

  • Limas Kupcinskas

  • Richard B. Gearry

  • Johannes R. Hov

  • Vibeke Andersen

  • Jean-Frederic Colombel

Medical Centers

  • Gastrointestinal unit, University of Edinburgh, Edinburgh, United Kingdom

  • Queensland Institute of Medical Research, Brisbane, Australia

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands

  • Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia

  • Preventative Health National Research Flagship, CSIRO, Brisbane, QLD, Australia

  • Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, ON, Canada

  • Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom

  • Department of Medicine III, University Hospital Grosshadern/LMU, Munich, Germany

  • Gastroenterology Unit, IRCCS-CSS Hospital, San Giovanni Rotondo, Italy

  • Clinic for Specialized Medicine and Surgery, Oslo University Hospital Rikshospitalet, Oslo, Norway

  • School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • Department of Hepato-Gastroenterology, Hospital Huriez, Lille, France

  • Medical Department, Viborg Regional Hospital, Viborg, Denmark

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Health Studies, The University of Chicago, Chicago, IL

  • Meyerhoff Inflammatory Bowel Disease Center, Johns Hopkins University, Baltimore, MD

  • Division of. Gastroenterology, Dept. of Medicine, Orebro University Hospital, Orebro, Sweden

  • Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Locations

  • Canada

  • Italy

  • Norway

  • Netherlands

  • Germany

  • United Kingdom

  • Sweden

  • Australia

  • United States

  • Lithuania

  • France

  • Denmark

  • Belgium

  • New Zealand

Companies

  • Genetics Institute,

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

Biomarkers

  • C reactive protein

Drug/Treatment

  • Cyclosporine eent

  • Infliximab

Outcome

  • N/A

Study Design

  • cross over

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved